Matches 1 - 50 out of 224 1 2 3 4 5 >

AcclaimIP-ad

Match Document Document Title
US20140058340 Eyelid Margin Wipes Comprising Chemical Means For Temperature Adjustment  
An eyelid margin wipe comprising chemical means for adjusting the temperature of the wipe relative to the ambient temperature. The wipe is particularly useful for treatment of disorders of the...
US20130267610 NOVEL LIPID DIPEPTIDE AND GEL  
There is provided a gelator that is capable of forming a gel by an extremely small amount of addition in a wide pH range from acidic to alkaline regions, and a gel having high environmental...
US20130251644 Cyclodextrin-Based Microemulsions, and Dermatological Uses Thereof  
Described herein are cyclodextrin-stabilized microemulsion systems useful for increasing the solubility, stability, bioavailability, or safety of an active agent for delivery to the skin. The...
US20120264681 BUFFERED OPHTHALMIC COMPOSITIONS AND METHODS OF USE THEREOF  
The present disclosure provides a buffered ophthalmic composition for formulation of topically administrable suspensions useful for treating eye disorders by promoting wound healing, delivery of...
US20110046606 Catheter injectable depot compositions and uses thereof  
Catheter injectable depot compositions are provided that include a bioerodible, biocompatible polymer, a solvent having miscibility in water of less than or equal to 7 wt. % at 25° C., in an...
US20090035372 METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF AN ACTIVE SUBSTANCE  
The present invention pertains to a sized product, which contains a drug, polyethylene oxide with a molecular weight of 2,000,000 or higher, and a specific size controlling agent for polyethylene...
US20140335034 Consumer Products Comprising Silane-Modified Oils  
A consumer product comprises silane-modified oil comprising a hydrocarbon chain selected from the group consisting of: a saturated oil, an unsaturated oil, and mixtures thereof; and at least one...
US20130253015 Cyclodextrin-Based Microemulsions, and Dermatological Uses Thereof  
Described herein are cyclodextrin-stabilized microemulsion systems useful for increasing the solubility, stability, bioavailability, or safety of an active agent for delivery to the skin. The...
US20120064134 COLOR ENHANCEMENT UTILIZING UP CONVERTERS AND DOWN CONVERTERS  
A light emitting composition including first color emitters and second color emitters. The first color emitters are configured to emit, upon exposure to an energy source, visible light at a target...
US20110105620 ORGANIC COMPOUNDS  
A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol.
US20080311182 MULTISTAGE DELIVERY OF ACTIVE AGENTS  
Multistage delivery vehicles are disclosed which include a first stage particle and a second stage particle. The first stage particle is a micro or nanoparticle that contains the second stage...
US20080107731 DPP IV INHIBITOR FORMULATIONS  
The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.
US20160228359 OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC CONDITIONS  
Compositions, and methods of using such compositions, useful for placement, for example injection, into the interior of human or animal eyes are provided. Such compositions include a therapeutic...
US20120136021 OXIDATION-STABILIZED TAMPER-RESISTANT DOSAGE FORM  
A thermoformed pharmaceutical dosage form having a breaking strength of at least 300 N, said dosage form comprisinga pharmacologically active ingredient (A),a free physiologically acceptable acid...
US20120132204 UNIT DOSE DRY POWDER INHALER  
An inhaler includes a first body member and a second body member fit closely together to form an inhaler body, and an outlet. The first body member has a medicament chamber containing a unit dose...
US20110136912 OPHTHALMIC EMULSION  
The present invention is directed to an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The...
US20090252767 Water dispersible enteric coating formulation of nutraceutical and pharmaceutical dosage forms  
The present invention relates to formulations for use as enteric coatings. More particularly, the present invention relates to a formulation comprising a dry blend of food grade ingredients that...
US20090104263 5-HT4 partial agonist pharmaceutical compositions  
A solid pharmaceutical composition for oral administration comprising tegaserod in base or salt form in an amount of up to 10% by weight a bulking agent in an amount of 70 to 90% by weight a...
US20140322282 Microcrystalline Cellulose Compositions  
Ultra-fine microcrystalline cellulose compositions are disclosed which comprise co-attrited microcrystalline cellulose and a hydrocolloid. The compositions have a mean particle size of less than...
US20130172374 SOLID COMPOSITION FOR CONTROLLED RELEASE OF IONIZABLE ACTIVE AGENTS WITH POOR AQUEOUS SOLUBILITY AT LOW PH AND METHODS OF USE THEREOF  
A novel solid composition and methods for making and using the solid composition are provided. The solid composition comprises: (a) at least one active agent with a solubility of less than about...
US20100144895 EMBOLIC COMPOSITIONS WITH NON-CYANOACRYLATE RHEOLOGY MODIFYING AGENTS  
Compositions for embolization are disclosed herein. The compositions disclosed can have a matrix-forming component, a solid-aggregate material, and a rheology modifying agent, wherein the...
US20100016443 METHOD FOR PREPARING PARTICLES COMPRISING METAL OXIDE COATING AND PARTICLES WITH METAL OXIDE COATING  
The invention relates to a process for coating a solid, water-insoluble particulate matter, with a metal oxide comprising: (a) contacting the solid, water-insoluble particulate matter with an...
US20150182473 TRANSDERMAL PATCHES WITH DISCRETE CARBON NANOTUBES  
A transdermal patch comprising discrete open-ended carbon nanotubes is disclosed.
US20150079173 FORMULATIONS DECREASING PARTICLE EXHALATION  
Formulations have been developed for pulmonary delivery to treat or reduce the infectivity of diseases such as viral infections, especially tuberculosis, SARS, influenza and respiratory synticial...
US20140308239 CHIMERIC CYTOKINE FORMULATIONS FOR OCULAR DELIVERY  
Featured herein are vehicle formulations and formulations containing a chimeric cytokine designed for e.g., ocular delivery.
US20120134956 Colloidal metal compositions and methods  
The present invention comprises compositions and methods for delivery systems of agents, including therapeutic compounds, pharmaceutical agents, drugs, detection agents, nucleic acid sequences and...
US20110171188 NON-THERMAL PLASMA FOR WOUND TREATMENT AND ASSOCIATED APPARATUS AND METHOD  
The invention relates to a non-thermal plasma for treatment of a surface, particularly for the treatment of a wound (1), wherein the plasma comprises a partially ionized carrier gas and at least...
US20090053290 TRANSDERMAL DRUG DELIVERY COMPOSITIONS AND TOPICAL COMPOSITIONS FOR APPLICATION ON THE SKIN  
Transdermal delivery compositions and topical compositions for application to the skin are provided. The transdermal delivery composition includes at least two penetrants working synergistically...
US20080214557 METHOD FOR PREPARATION OF PHARMACEUTICAL COMPOSITION HAVING IMPROVED DISINTEGRATABILITY AND PHARMACEUTICAL COMPOSITION MANUFACTURED BY SAME METHOD  
There exists a strong desire both for pharmaceutical compositions which rapidly exhibit pharmacological effects without an increase in the size of the dosage form or a decline in quality due to...
US20160279281 ORGANOPHOSPHOROUS, MULTIVALENT METAL COMPOUNDS, & POLYMER ADHESIVE INTERPENETRATING NETWORK COMPOSITIONS & METHODS  
Certain small molecule amino acid phosphate compounds such as phosphoserine and certain multivalent metal compounds such as calcium phosphate containing cements have been found to have improved...
US20130065885 ORAL THERAPEUTIC COMPOUND DELIVERY SYSTEM  
The present invention relates generally to therapeutic formulations. More particularly, this present invention provides an oral delivery system for a therapeutic compound that is a base, a salt of...
US20100040678 ORGANIC COMPOUNDS  
The present invention provides various pharmaceutical compositions comprising an S1P receptor modulator, e.g. an S1P receptor agonist. In one aspect, there is provided a pharmaceutical composition...
US20090226507 HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS  
A method is provided for increasing the permeability of skin or mucosal tissue to topically or transdermally administered pharmacologically or cosmeceutically active agents. The method involves...
US20140171319 Aqueous Composition Comprising a Pesticide and a Base Selected from an Alkali Salt of Hydrogencarbonate  
The invention relates to a liquid aqueous composition, which has a pH value of at least 7.0, comprising a pesticide and a base selected from an alkali salt of hydrogencarbonate; a method for...
US20120308487 Carnallite Preparation and Uses Thereof in Edible Applications  
The present invention relates to a Carnallite salt preparation useful in edible products, such as a food, beverage, dietary supplement, oral care, nutraceutical pet food, animal feed,...
US20110288363 Biologically Enhanced Irrigants  
Compositions, systems and methods utilizing engineered surgical irrigants providing delivery of components with therapeutic or other secondary benefits. Engineered irrigants provide targeted...
US20130095147 SOL-GEL DERIVED BIOACTIVE GLASS POLYMER COMPOSITE  
A bioactive sol-gel solution includes a biocompatible polymer, a gelable inorganic base material, and at least one calcium and phosphorous molecular species. The base material can be an alkoxide,...
US20120295986 CALCIUM SEQUESTERING COMPOSITION  
This invention relates to compositions which are capable of sequestering calcium ions and are derived in part from renewable carbohydrate feedstocks. The calcium sequestering compositions are...
US20100113616 INHIBITION OF DISCOLORATION BY WASHING AND CLEANING AGENTS AND/OR COSMETIC AGENTS  
Method of inhibiting discoloration in agents by incorporating iodide salt(s), preferably calcium, potassium and/or sodium iodides into the formulation of those agents. The method is particularly...
US20090155325 FORMULATION AND PRODUCTS FOR PROMOTING SKIN CLEANLINESS AND HEALTH  
The present disclosure generally relates to a formulation. More particularly, the formulation may be applied to skin and/or used in combination with a personal care product to improve absorbance...
US20140275287 Compositions and Methods for Hemostasis  
The present invention relates to water soluble and completely absorbable and/or physiologically degradable hemostatic compositions having a wax or wax-like base effective for use in tamponade...
US20090177273 ANISOTROPIC NANOPOROUS COATINGS FOR MEDICAL IMPLANTS  
The present invention relates to a process for fabricating a porous coatings with controlled structure in the micro and nano-size domain. In particular, but not exclusively, it relates to a...
US20160136097 ULTRAFAST-DISINTEGRATING TABLET AND METHOD FOR MANUFACTURING SAME  
An object of the present invention is to provide an orally disintegrating tablet (ultrafast-disintegrating tablet) having an extremely high disintegrability (short disintegration time), and a high...
US20140294948 COMPOSITION AS AUXILIARY MEANS FOR ORAL MEDICATION  
The invention relates in one aspect to a composition, specifically a jelly, the use of which composition as an auxiliary means is to ease the taking of oral medication in solid form, which...
US20130156871 Nasal Wash Solution  
A composition provides an isotonic nasal irrigation solution with pH less than about 7.0. The composition may be formed of a salt and a pH buffer and may include an additive. The composition may...
US20100240770 Synthesis and use of colloidal III-V nanoparticles  
A colloidal suspension of III-V semiconductor nanoparticles.
US20100143481 METHOD OF PREPARING SOLID DOSAGE FORMS OF MULTI-PHASIC PHARMACEUTICAL COMPOSITIONS  
Pharmaceutical formulations comprising a multi-phasic pharmaceutical composition, and an adsorbent carrier, where the pharmaceutical formulation is a solid dosage form. Methods for preparing such...
US20090297615 NANOPARTICLES, METHODS OF MAKING SAME AND CELL LABELING USING SAME  
There are disclosed polyhedral superparamagnetic nanoparticles and methods for making and using the nanoparticles. There are also disclosed coated and functionalized forms of the nanoparticles,...
US20090041695 Compositions for making up keratinous materials  
The present invention relates to a cosmetic composition comprising: a physiologically acceptable medium;monodisperse particles suitable for forming an ordered lattice of monodisperse particles on...
US20080233206 COMPOSITIONS AND METHODS FOR ANTI-INFLAMMATORY TREATMENTS  
The present invention relates to an improved method for treating a wide range of inflammatory disorders by administering a tetracycline compound together with an effective inhibitor of...
Matches 1 - 50 out of 224 1 2 3 4 5 >